✦ LIBER ✦

Vascular disruptive syndromes after exposure to misoprostol or chorionic villus sampling

✍ Scribed by Frans J Los; Helen Brandenburg; Martinus F Niermeijer

Book ID: 117295719
Publisher: The Lancet
Year: 1999
Tongue: English
Weight: 84 KB
Volume: 353
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)76507-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CHORIONIC VILLUS SAMPLING AND MATERNO-FE

CHORIONIC VILLUS SAMPLING AND MATERNO-FETAL TRANSFUSIONS: AN IMMUNOLOGICAL PATHOGENESIS OF VASCULAR DISRUPTIVE SYNDROMES?

✍ FRANS J. LOS; PETRA NOOMEN; CHRISTL VERMEIJ-KEERS; JOHANNES L. J. GAILLARD; HELE 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 985 KB

Experimental materno-embryonic transfusions with serum that is immunologically active against blood group antigens cause congenital malformations in the rat embryo. In view of the possible increased incidence of vascular disruptive syndromes after chorionic villus sampling (CVS), we investigated the

Prenatal diagnosis of the carbohydrate-d

Prenatal diagnosis of the carbohydrate-deficient glycoprotein syndrome type 1A (CDG1A) by a combination of enzymology and genetic linkage analysis after amniocentesis or chorionic villus sampling

✍ Joanne Charlwood; Peter Clayton; Geoffrey Keir; Nasi Mian; Elisabeth Young; Brya 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 1 views

Two pregnancies at risk for the carbohydrate-deficient glycoprotein syndrome Type 1A (CDG1A, phosphomannomutase deficient) were monitored by enzyme and genetic linkage analyses. The index case in both families had a proven deficiency of phosphomannomutase (PMM). An unaffected fetus was predicted in